Invention Grant
- Patent Title: Heterocyclic derivatives and their use in the treatment of neurological disorders
-
Application No.: US16378887Application Date: 2019-04-09
-
Publication No.: US10683287B2Publication Date: 2020-06-16
- Inventor: Sangamesh Badiger , Murali Chebrolu , Konstanze Hurth , Sebastien Jacquier , Rainer Martin Lueoend , Rainer Machauer , Heinrich Rueeger , Marina Tintelnot-Blomley , Siem Jacob Veenstra , Markus Voegtle
- Applicant: Novartis AG
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Agency: Honigman LLP
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@774f7d64
- Main IPC: C07D413/04
- IPC: C07D413/04 ; C07D413/14 ; C07D471/04 ; C07D487/04 ; A61K31/5377 ; C07B59/00
Abstract:
The invention relates to novel heterocyclic compounds of the formula in which all of the variables are as defined in the specification, pharmaceutical compositions thereof, combinations thereof, and their use as medicaments, particularly for the treatment of Alzheimer's Disease or diabetes via inhibition of BACE-1 or BACE-2.
Public/Granted literature
- US20200048236A1 Novel Heterocyclic Derivatives and Their Use in the Treatment of Neurological Disorders Public/Granted day:2020-02-13
Information query
